Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic Telangiectasia: Complete Statistical AnalysisIndependent statistical analysis of Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic Telangiectasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00588146).
- Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00369681).
- Phase 2 Study of Rivaroxaban Reversal by Ciraparantag as Measured by WBCT: Complete Statistical AnalysisIndependent statistical analysis of Phase 2 Study of Rivaroxaban Reversal by Ciraparantag as Measured by WBCT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS): Complete Statistical AnalysisIndependent statistical analysis of Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Phase 2 Study of XAF5 (XOPH5) Ointment for Reduction of Excess Eyelid Fat (Steatoblepharon): Complete Statistical AnalysisIndependent statistical analysis of Phase 2 Study of XAF5 (XOPH5) Ointment for Reduction of Excess Eyelid Fat (Steatoblepharon): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Phase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high Asthma: Complete Statistical AnalysisIndependent statistical analysis of Phase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Phase 2 Study to Investigate the Efficacy and Safety of Aldoxorubicin in Subjects With Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of Phase 2 Study to Investigate the Efficacy and Safety of Aldoxorubicin in Subjects With Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Phase 2 Study With Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment for Newly Diagnosed Multiple Myeloma (MM) With Upfront Daratumumab-based Therapy: Complete Statistical AnalysisIndependent statistical analysis of Phase 2 Study With Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment for Newly Diagnosed Multiple Myeloma (MM) With Upfront Daratumumab-based Therapy: primary endpoint results, effect estimate…
- Phase 2 Study: An Open-Label, Randomized, Phase 2 Dose-Finding Study of Pacritinib in Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post- Essential Thrombocythemia Myelofibrosis Previously Treated With Ruxolitinib: Complete Statistical AnalysisIndependent statistical analysis of Phase 2 Study: An Open-Label, Randomized, Phase 2 Dose-Finding Study of Pacritinib in Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post- Essential Thrombocythemia Myelofibrosis Previously Treated With…
- Phase 2 Total Skin Electron Beam Therapy (TSEBT 12 Gy) in Stage IB-IIIA Mycosis Fungoides: Complete Statistical AnalysisIndependent statistical analysis of Phase 2 Total Skin Electron Beam Therapy (TSEBT 12 Gy) in Stage IB-IIIA Mycosis Fungoides: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment: Complete Statistical AnalysisIndependent statistical analysis of Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Phase 2 Trial of Regorafenib in Patients With Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer: Complete Statistical AnalysisIndependent statistical analysis of Phase 2 Trial of Regorafenib in Patients With Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence: Complete Statistical AnalysisIndependent statistical analysis of Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00687713).
- Phase 2, Multi-center, Randomized, Double- Masked and Placebo-Controlled Study of YP-P10 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (ICECAP 1): Complete Statistical AnalysisIndependent statistical analysis of Phase 2, Multi-center, Randomized, Double- Masked and Placebo-Controlled Study of YP-P10 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (ICECAP 1): primary endpoint results, effect estimate…
- Phase 2, Open-Label, Multi-Dose Study of Panhematin in Patients With MDS: Complete Statistical AnalysisIndependent statistical analysis of Phase 2, Open-Label, Multi-Dose Study of Panhematin in Patients With MDS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca: Complete Statistical AnalysisIndependent statistical analysis of Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Phase 2A Clinical Trial Evaluating the Potential Activity and Safety of hMaxi-K Gene for ED: Complete Statistical AnalysisIndependent statistical analysis of Phase 2A Clinical Trial Evaluating the Potential Activity and Safety of hMaxi-K Gene for ED: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC): Complete Statistical AnalysisIndependent statistical analysis of Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Phase 2a Study of ZW25 in Combination With Palbociclib Plus Fulvestrant: Complete Statistical AnalysisIndependent statistical analysis of Phase 2a Study of ZW25 in Combination With Palbociclib Plus Fulvestrant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Phase 2a Study to Assess CIVI 007 in Patients on a Background of Statin Therapy: Complete Statistical AnalysisIndependent statistical analysis of Phase 2a Study to Assess CIVI 007 in Patients on a Background of Statin Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects: Complete Statistical AnalysisIndependent statistical analysis of Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects: primary endpoint results, effect estimate with confidence…
- Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT): Complete Statistical AnalysisIndependent statistical analysis of Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo: Complete Statistical AnalysisIndependent statistical analysis of Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo: primary…
- Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL): Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Participants With Specific Gene Defects in the MC4R Pathway: Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Participants With Specific Gene Defects in the MC4R Pathway: primary endpoint results, effect estimate with confidence interval, sample-size…
- Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301.: Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea: Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema of Rosacea: Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema of Rosacea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Phase 3 Open-label Study to Evaluate the Response and Safety of Kuvan® in Subjects With Phenylketonuria: Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Open-label Study to Evaluate the Response and Safety of Kuvan® in Subjects With Phenylketonuria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Phase 3 Papulopustular Rosacea Study: Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Papulopustular Rosacea Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01493687).
- Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism: Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Phase 3 Study Evaluating Efficacy, Safety and Pharmacokinetics of Trilaciclib In Small Cell Lung Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Study Evaluating Efficacy, Safety and Pharmacokinetics of Trilaciclib In Small Cell Lung Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery: Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size…
- Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area: Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area: primary endpoint results, effect estimate with confidence…
- Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Phase 3 Study of OTO-201 in Acute Otitis Externa: Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Study of OTO-201 in Acute Otitis Externa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02801370).
- Phase 3 Study of TAK-438 10 mg in the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD): Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Study of TAK-438 10 mg in the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin: Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin: primary endpoint results, effect estimate…
- Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab: Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies: Complete Statistical AnalysisIndependent statistical analysis of Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Phase 3/Safety & Efficacy of Esomeprazole in Infants: Complete Statistical AnalysisIndependent statistical analysis of Phase 3/Safety & Efficacy of Esomeprazole in Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00468559).
- Phase 4 Comparative Trial of Benzathine Penicillin G for Treatment of Early Syphilis in Subjects With or Without HIV Infection: Complete Statistical AnalysisIndependent statistical analysis of Phase 4 Comparative Trial of Benzathine Penicillin G for Treatment of Early Syphilis in Subjects With or Without HIV Infection: primary endpoint results, effect estimate with confidence interval,…
- Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE): Complete Statistical AnalysisIndependent statistical analysis of Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE): primary endpoint results, effect estimate with confidence interval, sample-size…
- Phase IIndependent statistical analysis of Electrical Stimulation for Critically Ill Covid-19 Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04685213).
- Phase I Clinical Human Tolerability Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10: Complete Statistical AnalysisIndependent statistical analysis of Phase I Clinical Human Tolerability Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers: primary endpoint…
- Phase I Clinical Trial of GRID Therapy in Pediatric Osteosarcoma of the Extremity: Complete Statistical AnalysisIndependent statistical analysis of Phase I Clinical Trial of GRID Therapy in Pediatric Osteosarcoma of the Extremity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…